Erythrasma laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:
===Culture===
===Culture===
*An [[epidermal]] swab of the affected region may provide samples of the pathogenic ''[[Corynebacterium|Corynebacterium minitissimum]]''.<ref name="pmid12010076">{{cite journal |vauthors=Holdiness MR |title=Management of cutaneous erythrasma |journal=Drugs |volume=62 |issue=8 |pages=1131–41 |year=2002 |pmid=12010076 |doi= |url=}}</ref>
*An [[epidermal]] swab of the affected region may provide samples of the pathogenic ''[[Corynebacterium|Corynebacterium minitissimum]]''.<ref name="pmid12010076">{{cite journal |vauthors=Holdiness MR |title=Management of cutaneous erythrasma |journal=Drugs |volume=62 |issue=8 |pages=1131–41 |year=2002 |pmid=12010076 |doi= |url=}}</ref>
**''[[Corynebacterium|Corynebacterium minitissimum]]'' will present as non-[[hemolytic]] smooth colonies that are 1-1.5mm in size.<ref name="pmid15310342">{{cite journal |vauthors=Karakatsanis G, Vakirlis E, Kastoridou C, Devliotou-Panagiotidou D |title=Coexistence of pityriasis versicolor and erythrasma |journal=Mycoses |volume=47 |issue=7 |pages=343–5 |year=2004 |pmid=15310342 |doi=10.1111/j.1439-0507.2004.00997.x |url=}}</ref>
**''[[Corynebacterium|Corynebacterium minutissimum]]'' will present as non-[[hemolytic]] smooth colonies that are 1-1.5mm in size.<ref name="pmid15310342">{{cite journal |vauthors=Karakatsanis G, Vakirlis E, Kastoridou C, Devliotou-Panagiotidou D |title=Coexistence of pityriasis versicolor and erythrasma |journal=Mycoses |volume=47 |issue=7 |pages=343–5 |year=2004 |pmid=15310342 |doi=10.1111/j.1439-0507.2004.00997.x |url=}}</ref>
**''[[Corynebacterium|Corynebacterium minutissimum]]'' can be distinguished from other [[serotypes]] by its lack of necessity for [[lipids]] to grow in vitro.<ref name="pmid2116939">{{cite journal |vauthors=Coyle MB, Lipsky BA |title=Coryneform bacteria in infectious diseases: clinical and laboratory aspects |journal=Clin. Microbiol. Rev. |volume=3 |issue=3 |pages=227–46 |year=1990 |pmid=2116939 |pmc=358157 |doi= |url=}}</ref>  
*Due to the 2-3 week incubation requirements and the low sensitivity, culture analysis is not effective as a sole diagnostic measure.<ref name="pmid25477907">{{cite journal |vauthors=Sariguzel FM, Koc AN, Yagmur G, Berk E |title=Interdigital foot infections: Corynebacterium minutissimum and agents of superficial mycoses |journal=Braz. J. Microbiol. |volume=45 |issue=3 |pages=781–4 |year=2014 |pmid=25477907 |pmc=4204958 |doi= |url=}}</ref>
*Due to the 2-3 week incubation requirements and the low sensitivity, culture analysis is not effective as a sole diagnostic measure.<ref name="pmid25477907">{{cite journal |vauthors=Sariguzel FM, Koc AN, Yagmur G, Berk E |title=Interdigital foot infections: Corynebacterium minutissimum and agents of superficial mycoses |journal=Braz. J. Microbiol. |volume=45 |issue=3 |pages=781–4 |year=2014 |pmid=25477907 |pmc=4204958 |doi= |url=}}</ref>



Revision as of 17:32, 7 October 2016

Erythrasma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Erythrasma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Erythrasma laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Erythrasma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Erythrasma laboratory findings

on Erythrasma laboratory findings

Erythrasma laboratory findings in the news

Blogs on Erythrasma laboratory findings

Directions to Hospitals Treating Erythrasma

Risk calculators and risk factors for Erythrasma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.

Overview

Laboratory Findings

Culture

Gram staining

References

  1. Holdiness MR (2002). "Management of cutaneous erythrasma". Drugs. 62 (8): 1131–41. PMID 12010076.
  2. Karakatsanis G, Vakirlis E, Kastoridou C, Devliotou-Panagiotidou D (2004). "Coexistence of pityriasis versicolor and erythrasma". Mycoses. 47 (7): 343–5. doi:10.1111/j.1439-0507.2004.00997.x. PMID 15310342.
  3. Coyle MB, Lipsky BA (1990). "Coryneform bacteria in infectious diseases: clinical and laboratory aspects". Clin. Microbiol. Rev. 3 (3): 227–46. PMC 358157. PMID 2116939.
  4. Sariguzel FM, Koc AN, Yagmur G, Berk E (2014). "Interdigital foot infections: Corynebacterium minutissimum and agents of superficial mycoses". Braz. J. Microbiol. 45 (3): 781–4. PMC 4204958. PMID 25477907.
  5. Granok, Alexander B.; Benjamin, Patti; Garrett, Lee S. (2002). "Corynebacterium minutissimumBacteremia in an Immunocompetent Host with Cellulitis". Clinical Infectious Diseases. 35 (4): e40–e42. doi:10.1086/341981. ISSN 1058-4838.
  6. Shin JY, Lee WK, Seo YH, Park YS (2014). "Postoperative Abdominal Infection Caused by Corynebacterium minutissimum". Infect Chemother. 46 (4): 261–3. doi:10.3947/ic.2014.46.4.261. PMC 4285009. PMID 25566407.

Template:WS Template:WH